Liberty Mutual Group Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-25,275
Closed -$1.47M – 280
2018
Q3
$1.47M Hold
25,275
– – 0.03% 228
2018
Q2
$1.23M Buy
25,275
+27
+0.1% +$1.26K 0.03% 284
2018
Q1
$1.17M Hold
25,248
– – 0.04% 305
2017
Q4
$949K Sell
25,248
-3,387
-12% -$124K 0.03% 484
2017
Q3
$1.04M Sell
28,635
-13,146
-31% -$501K 0.06% 432
2017
Q2
$1.65M Buy
41,781
+6,816
+19% +$249K 0.07% 379
2017
Q1
$1.1M Sell
34,965
-12,351
-26% -$387K 0.04% 600
2016
Q4
$1.48M Buy
47,316
+765
+2% +$24.8K 0.05% 508
2016
Q3
$1.87M Buy
46,551
+1,170
+3% +$44.1K 0.07% 361
2016
Q2
$1.51M Buy
45,381
+3,138
+7% +$107K 0.06% 434
2016
Q1
$1.24M Buy
42,243
+4,377
+12% +$121K 0.05% 485
2015
Q4
$997K Sell
37,866
-32,166
-46% -$835K 0.04% 657
2015
Q3
$1.66M Sell
70,032
-4,098
-6% -$98.9K 0.06% 483
2015
Q2
$1.76M Sell
74,130
-23,310
-24% -$526K 0.06% 508
2015
Q1
$2.31M Sell
97,440
-510
-0.5% -$11.4K 0.07% 415
2014
Q4
$2.08M Sell
97,950
-29,628
-23% -$595K 0.07% 505
2014
Q3
$2.17M Sell
127,578
-6,066
-5% -$95.8K 0.07% 389
2014
Q2
$1.91M Sell
133,644
-16,260
-11% -$220K 0.06% 529
2014
Q1
$1.85M Sell
149,904
-42,030
-22% -$485K 0.06% 511
2013
Q4
$2.1M Buy
191,934
+151,236
+372% +$1.7M 0.07% 304
2013
Q3
$472K Buy
40,698
+8,268
+25% +$96.7K 0.02% 910
2013
Q2
$363K Buy
+32,430
New +$384K 0.01% 907

Other funds holding EW

Liberty Mutual Group Asset Management's EW Position: Q4 2018 in Review

Liberty Mutual Group Asset Management sold out of Edwards Lifesciences (EW) in Q4 2018, closing a stake of 25,275 shares — an estimated $1.47M sold.

Liberty Mutual Group Asset Management first reported a position in EW in Q2 2013 and held it in 22 quarters. The position peaked at $2.31M in Q1 2015. 875 funds tracked by Wall St. Rank hold EW as of Q4 2018.

  • Liberty Mutual Group Asset Management reported no remaining Edwards Lifesciences position as of Q4 2018 after selling out during the quarter.
  • Liberty Mutual Group Asset Management sold 25,275 Edwards Lifesciences shares in Q4 2018, an estimated $1.47M.
  • Liberty Mutual Group Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and held it in 22 quarters.
  • Liberty Mutual Group Asset Management's Edwards Lifesciences position peaked at $2.31M in Q1 2015.
  • 875 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2018.

Based on Liberty Mutual Group Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.